New Brunswick, New Jersey--(Newsfile Corp. - November 21, 2024) - Octaviant Financial, Inc. (OFX), a recognized innovator in drug warranty and payment models, announced today that Starr Insurance will join Octaviant and Marsh, the world’s leading insurance broker and risk advisor, in offering drug warranty services that enable pharmaceutical companies to stand behind the effectiveness of high-cost therapies. Octaviant will provide its drug warranties under the terms of the partnership through its subsidiary, Actuaria Insurance Services LLC.

To view the full announcement, including downloadable images, bios, and more, click here.

Key Takeaways:

• Octaviant Financial's collaboration with Starr Insurance enhances its drug warranty platform by providing pharmaceutical companies a dedicated carrier to underwrite and distribute their drug warranties.

• With the inclusion of an insurance carrier that understands the complex regulatory requirements to issue these instruments, pharmaceutical companies will be able to offer valuable drug assurance programs that will resonate with payers, reduce the risks associated with failure, and differentiate pharmaceutical products in the market.

• Octaviant Financial also announced the formation of Actuaria Insurance Services LLC, a licensed insurance agency wholly owned by Octaviant Financial specializing in drug assurance program administration services to pharmaceutical and insurance companies.

Click image above to view full announcement.

About Octaviant Financial

Octaviant Financial offers innovative financial, warranty and reinsurance solutions designed to help drug makers, payers and patients manage the cost of gene, cell and specialty therapies. Octaviant's mission is to facilitate the adoption of transformational therapies by removing significant barriers for payers and patients seeking access. Our core strength is to leverage our combined experiences in the life sciences, finance, insurance, and reinsurance industries to meet our mission. Octaviant's culture - to be innovative, collaborative, and client-centric - has allowed the firm to develop cutting edge ideas to fuel its proprietary instruments and services offerings. We provide full-service advice to our clients and assist them to think strategically through the most complex challenges facing drug delivery and reimbursement. In doing so, it is our hope that a healthcare system evolves to bring about more cures for patients living with disease. For more information, visit www.octaviantfx.com or follow us on LinkedIn.

About Starr Insurance

Starr Insurance (or Starr) is a marketing name for the operating insurance and travel assistance companies and subsidiaries of Starr International Company, Inc. and for the investment business of C. V. Starr & Co., Inc. and its subsidiaries. Starr is a leading insurance and investment organization with a presence on six continents; through its operating insurance companies, Starr provides property, casualty, and accident and health insurance products as well as a range of specialty coverages including aviation, marine, energy and excess casualty insurance. Starr's insurance company subsidiaries domiciled in the U.S., Bermuda, China, Hong Kong, Malta, Singapore, Switzerland and U.K. each have an A.M. Best rating of "A" (Excellent). Starr's Lloyd's syndicate has a Standard & Poor's rating of "A+" (Strong).

About Marsh

Marsh is the world's leading insurance broker and risk advisor. With more than 45,000 colleagues advising clients in over 130 countries, Marsh serves commercial and individual clients with data-driven risk solutions and advisory services. Marsh is a business of Marsh McLennan (NYSE: MMC), the world's leading professional services firm in the areas of risk, strategy and people. With annual revenue of $23 billion, Marsh McLennan helps clients navigate an increasingly dynamic and complex environment through four market-leading businesses: Marsh, Guy Carpenter, Mercer and Oliver Wyman. For more information, visit marsh.com, and follow us on LinkedIn and X.

Source: Octaviant Financial, Inc.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/230862